February 27, 2020
Merck to Present at the Cowen Health Care Conference
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Robert M.…
Pharmaceuticals, Biotechnology and Life Sciences
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Robert M.…
ZULRESSO™ (brexanolone) CIV injection net revenues of $2M and $4M for fourth quarter and full year 2019, respectively Evaluating path…
Neurovascular Device Portfolio Development and Global Clinical Trials IRVINE, Calif.–(BUSINESS WIRE)–#medicaldevice–NeuroVasc Technologies, Inc. announced that it has entered into a…
CAMBRIDGE, Mass. & ROTTERDAM, Netherlands & SUZHOU, China–(BUSINESS WIRE)–Harbour BioMed (HBM) today announced U.S. Food and Drug Administration (FDA) approval…
Quarterly net revenues of $99.2 million, representing 42 percent growth versus the fourth quarter 2018 and 8 percent growth versus…
Quarterly net revenues of $99.2 million, representing 42 percent growth versus the fourth quarter 2018 and 8 percent growth versus…
DUBLIN–(BUSINESS WIRE)–The “Tyrosine Protein Kinase SYK – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. The…
DUBLIN–(BUSINESS WIRE)–The “Tyrosine Protein Kinase SYK – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. The…
SAN DIEGO–(BUSINESS WIRE)–#bio—Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today…
SAN DIEGO–(BUSINESS WIRE)–#bio—Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today…